Q2 FY2025 Earnings
Financial report interval: 2024.10.01 - 2024.12.31
Overview: PROPANC BIOPHARMA INC(PPCBD) the EBIT is -213.38 K (+51.29%);the EPS is -32.23 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B51.29%
----
----
EPS
-32.2307--
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf